Navigating the Maze: Expert Guidance on Understanding and Integrating Biosimilars in Practice

Navigating the Maze: Expert Guidance on Understanding and Integrating Biosimilars in Practice Biologics are therapies for managing immunologic and inflammatory disorders, cancer, and other conditions. However, patient access to biologic therapies has remained limited. Biosimilars and interchangeable products have the potential to increase access for patients and potentially lower treatment costs. Limited understanding of healthcare providers and patients and concerns about clinical performance of biosimilars and interchangeable products compared with the reference product have limited clinical use, despite biosimilars and interchangeable products being highly similar and producing the same clinical result with no clinically meaningful differences. https://www.medscape.org/advances/navigating-maze-2025a1000j2a?src=ban_driv_20260929mscpedu454809.01_ace